Valuation: Merck KGaA

Capitalization 53.37B 62.05B 48.82B 46.17B 85.27B 5,992B 86.75B 580B 226B 2,838B 233B 228B 9,856B P/E ratio 2026 *
20.6x
P/E ratio 2027 * 17.9x
Enterprise value 60.99B 70.9B 55.79B 52.77B 97.44B 6,847B 99.14B 662B 259B 3,243B 266B 260B 11,263B EV / Sales 2026 *
2.91x
EV / Sales 2027 * 2.68x
Free-Float
29.73%
Yield 2026 *
1.9%
Yield 2027 * 1.98%
1 day+1.99%
1 week+8.63%
Current month+11.54%
1 month+3.59%
3 months-4.03%
6 months+10.94%
Current year+0.12%
1 week 115.65
Extreme 115.65
122.9
1 month 106.6
Extreme 106.6
123.6
Current year 100.7
Extreme 100.7
131.65
1 year 100.7
Extreme 100.7
131.65
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 60 01/05/2026
Director of Finance/CFO 55 01/07/2023
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member - 26/04/2019
Director/Board Member 63 01/05/2012
Director/Board Member 77 09/05/2014
Change 5d. change 1-year change 3-years change Capi.($)
+1.99%+8.63%+6.74%-26.25% 60.67B
+0.36%-2.75%+29.43%+103.66% 8.15B
-0.21%+1.99%+5.48%-11.63% 7.84B
-2.15%-11.31%+2.02%+27.99% 4.82B
+0.25%-4.00%-22.89%+48.31% 4B
+0.25%-7.69%-0.02%-27.47% 3.01B
+2.25%-3.64%+47.32%+37.97% 2.76B
-1.93%-3.34%+16.58%-10.48% 2.41B
-6.72%-11.02%+37.83%-3.88% 1.86B
-0.27%-7.08%+67.94%+24.82% 1.89B
Average -0.62%-3.85%+19.04%+16.30% 9.74B
Weighted average by Cap. +1.05%+2.50%+10.05%-4.86%

Financials

2026 *2027 *
Net sales 20.99B 24.4B 19.2B 18.16B 33.53B 2,356B 34.11B 228B 89.04B 1,116B 91.55B 89.61B 3,876B 22.01B 25.58B 20.13B 19.04B 35.16B 2,471B 35.77B 239B 93.37B 1,170B 96B 93.96B 4,064B
Net income 2.59B 3.01B 2.37B 2.24B 4.14B 291B 4.21B 28.15B 11B 138B 11.31B 11.07B 479B 2.96B 3.44B 2.7B 2.56B 4.72B 332B 4.8B 32.1B 12.54B 157B 12.89B 12.62B 546B
Net Debt 7.62B 8.86B 6.97B 6.59B 12.17B 856B 12.39B 82.76B 32.33B 405B 33.24B 32.54B 1,407B 5.53B 6.43B 5.06B 4.79B 8.84B 621B 9B 60.1B 23.48B 294B 24.14B 23.63B 1,022B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
59,077
Date Price Change Volume
20/05/26 122.75 +1.99% 394,036
19/05/26 120.35 +2.21% 457,980
18/05/26 117.75 +0.34% 300,986
15/05/26 117.35 -2.82% 334,857
14/05/26 120.75 -0.33% 236,302
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
122.75EUR
Average target price
142.67EUR
Spread / Average Target
+16.23%

Quarterly revenue - Rate of surprise